Citation 79204

ALALI,FQ: ZHANG,Y: ROGERS,LL: MC LAUGHLIN,JL:. (1997). (2,4-CIS AND TRANS)-GIGANTECINONE AND 4-DEOXYGIGANTECIN, BIOACTIVE NONADJACENT BIS-TETRAHYDROFURAN ANNONACEOUS ACETOGENINS, FROM GONIOTHALAMUS GIGANTEUS.. 60(9)

Citation Details

Title	(2,4-CIS AND TRANS)-GIGANTECINONE AND 4-DEOXYGIGANTECIN, BIOACTIVE NONADJACENT BIS-TETRAHYDROFURAN ANNONACEOUS ACETOGENINS, FROM GONIOTHALAMUS GIGANTEUS.
Authors	ALALI,FQ: ZHANG,Y: ROGERS,LL: MC LAUGHLIN,JL:
Year	1997
Volume	60
Issue	9

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECIN	STRONG ACTIVITY
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECIN	STRONG ACTIVITY
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECIN	STRONG ACTIVITY
4	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECIN	INACTIVE

Goniothalamus giganteus (ANNONACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORABSOLUTE CONFIGURATION DETERMINEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	GIGANTECINONE,CIS-2-4:	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECINONE,CIS-2-4:	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECINONE,CIS-2-4:	STRONG ACTIVITY
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECINONE,CIS-2-4:	ACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECINONE,CIS-2-4:	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECINONE,CIS-2-4:	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECINONE,CIS-2-4:	ACTIVE
8	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECINONE,CIS-2-4:	ACTIVE
9	LARVICIDAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GIGANTECINONE,CIS-2-4:	ACTIVE
10	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	GIGANTECINONE,TRANS-2-4:	None
11	Not specified	ISOLATION AND IDENTIFICATION OFABSOLUTE CONFIGURATION DETERMINEDPMR SPECTRUM REPORTEDCD SPECTRUM REPORTED FOR	GIGANTECIN,4-DEOXY:	None
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECIN,4-DEOXY:	ACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECIN,4-DEOXY:	ACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECIN,4-DEOXY:	ACTIVE
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECIN,4-DEOXY:	ACTIVE
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECIN,4-DEOXY:	ACTIVE
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECIN,4-DEOXY:	ACTIVE
18	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GIGANTECIN,4-DEOXY:	STRONG ACTIVITY
19	LARVICIDAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GIGANTECIN,4-DEOXY:	ACTIVE
20	Not specified	ISOLATION AND IDENTIFICATION OF	ANNONACIN,ISO: 2-4-TRANS:ANNONACIN,ISO: 2-4-CIS:LONGIMICIN C	None